Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 165 of 233 results for children's cancer

  1. Caris Molecular Intelligence for guiding cancer treatment (MIB120)

    NICE has developed a medtech innovation briefing (MIB) on Caris Molecular Intelligence for guiding cancer treatment .

    Medtech innovation briefing
    Published
    20 September 2017

  2. Archimedes for biopsy of suspected lung cancer (MIB211)

    NICE has developed a medtech innovation briefing (MIB) on Archimedes for biopsy of suspected lung cancer .

    Medtech innovation briefing
    Published
    11 June 2020

  3. LiMAx system for assessing the functional capacity of the liver (MIB168)

    NICE has developed a medtech innovation briefing (MIB) on LiMAx system for assessing the functional capacity of the liver .

    Medtech innovation briefing
    Published
    16 January 2019

  4. Guidance on the use of imatinib for chronic myeloid leukaemia (TA70)

    Evidence-based recommendations on imatinib for people with chronic myeloid leukaemia.

    Technology appraisal guidance
    Last updated
    21 January 2016
    View recommendations

    Sections for TA70

  5. Living-donor liver transplantation (IPG535)

    Evidence-based recommendations on living-donor liver transplantation. This involves replacing a diseased or damaged liver with a healthy one from a living human donor.

    Interventional procedures guidance
    Published
    25 November 2015
    View recommendations

    Sections for IPG535

  6. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  7. Early Value Assessment (EVA) for medtech

    NICE is trialling an innovative new approach to the way digital products, devices and diagnostics are assessed.

  8. What community-based interventions are effective and cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor oral health?

    cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of...

    Research recommendation
    Published
    9 June 2015

  9. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health?

    improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  10. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  11. News

    chemotherapy after surgery for early breast cancer More people with early breast cancer could be spared chemotherapy and...

  12. ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment (MIB39)

    NICE has developed a medtech innovation briefing (MIB) on ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment

    Medtech innovation briefing
    Published
    30 September 2015

  13. Committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  14. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are...

    Research recommendation
    Published
    21 October 2021

  15. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are...

    Research recommendation
    Published
    21 October 2021